Breaking News Headlines Today

News from MedCity News

See all of MedCity News news coverage in one place. Discover how MedCity News’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 335 have been published by MedCity News which Ground News has aggregated in the past 3 months.

MedCity News’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media, a Center rating from Media Bias/Fact Check .

If you want to know if MedCity News is credible or reliable, look no further. We rank MedCity News as High factuality. Find out more about our methodology here.

Information about MedCity News

Where is MedCity News located?MedCity News's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Center

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MedCity News News

Donald Trump · United States

Trump Orders Drug Stockpile, Increased Manufacturing

46% Center coverage: 13 sources

(The Center Square) – President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the United States.See the Story

Business · Germany

BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes

83% Center coverage: 6 sources

The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition. The post BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes appeared first on MedCity News.See the Story

Medical · United States

First Drug to Treat Bronchiectasis Lung Condition Approved by FDA

100% Center coverage: 5 sources

The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri.See the Story

Response Pharma’s Novel Pill for Weight Loss Shows Promise as Post-GLP-1 Maintenance Therapy

100% Center coverage: 1 sources

Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s lead indication is addressing weight gain in patients taking antipsychotics, the company is also exploring other metabolic indications such as patients who need a post-GLP-1 therapy. The post Response Pharma’s Novel Pill for Weight Loss Shows Promise as Post…See the Story

Healthcare Benefit Trends Report: Employers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions

100% Center coverage: 2 sources

The 2025 Benefits Sentiment Index, a survey of 120 benefit consultants to self-insured employers, focuses on healthcare navigation, GLP-1 drug coverage and AI trends for healthcare benefits. The post Healthcare Benefit Trends Report: Employers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions appeared first on MedCity News.Artificial Intelligence · Dublin See the Story

EMR Interoperability Isn’t Just a Hospital Problem. EMS Teams Need It Too.

100% Center coverage: 1 sources

In an era of real-time data, emergency response teams can no longer afford to operate in silos. EMR interoperability is essential to improving care continuity, outcomes, and decision-making — from curb to discharge. The post EMR Interoperability Isn’t Just a Hospital Problem. EMS Teams Need It Too. appeared first on MedCity News.See the Story

Florida’s New Stem Cell Law: What It Signals for Physicians, Patients and the Future of Regenerative Medicine

100% Center coverage: 1 sources

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and physicians across the country need to be prepared to understand and consider advising patients, where applicable, of these stem cell-related treatment options. The post Florida’s New Stem Cell Law: What It Signals for Physicians, Patients and the Future of Regenerative Medicine appeared first on MedCity News.Florida, United States · Florida Read Article

DiMe and 20+ Partners Seek to End the Quest for Better Mental Health Metrics

100% Center coverage: 1 sources

A new initiative from the Digital Medicine Society aims to replace outdated mental health questionnaires with a set of shared digital measures that track things like patients’ sleep, activity and speech. By relying on real-time, quantitative insights, the project seeks to set a data-driven standard for evaluating the effectiveness of mental health treatments.Read Article

News from MedCity News